Search for: "Andrx Corp." Results 1 - 20 of 43
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Jan 2017, 7:44 am by Rebecca Tushnet
Andrx Corp., 369 F.3d 700 (3d Cir. 2000), held that the first level of hearsay—employees recounting customer statements evincing confusion—aren’t excludable hearsay because they aren’t submitted for their truth, but rather for their error. [read post]
21 Nov 2015, 5:54 am by Gregory B. Williams
Andrx Corp., 369 F.3d 700, 711 (3d Cir. 2004), the Court concluded that AstraZeneca had carried its burden to prove that it would likely succeed on the merits of the case pursuant to the Lapp factors analysis, that it would likely suffer “irreparable harm” if the requested relief was not granted, and that the balance of hardships and the public interest weigh in its favor. [read post]
13 Nov 2015, 2:42 pm by Gregory B. Williams
Andrx Corp., 369 F.3d 700, 711 (3d Cir. 2004), the Court concluded that AstraZeneca had carried its burden to prove that it would likely succeed on the merits of the case, that it would likely suffer “irreparable harm” if the requested relief was not granted, and that the balance of hardships and the public interest weigh in its favor. [read post]
31 May 2015, 9:59 pm by Patent Docs
.; Andrx Corp.; Actavis Inc.; Actavis Pharma Inc. [read post]
19 Oct 2014, 9:14 pm by Patent Docs
.; Andrx Corp.; Actavis Inc.; Actavis Pharma Inc. [read post]
24 Jul 2012, 11:03 am by Don Burton
Andrx Corp., the Federal Circuit added some needed clarity to the concept of the “presumption of validity” in patent law, and did so in a way that may be helpful to accused infringers who are arguing that the prior art (technology already disclosed in a patent or in the public domain) renders a patent invalid. [read post]
11 Jan 2012, 2:02 pm
Andrx Pharm., LLC, 603 F.3d 935, 940 (Fed. [read post]